nanosomal tacrolimus / Intas, Jina Pharma - LARVOL DELTA

Efficacy and Safety of a Tacrolimus Lipid Suspension Enema in Mild-to-Moderate Ulcerative Colitis: A Multicenter, Prospective, Double-Blind, Phase II Randomized Controlled Trial. (PubMed, Clin Ther) - "Tacrolimus lipid suspension enema at both 2 and 4 mg doses was effective and well-tolerated. Both formulations also substantially improved patient-reported outcomes."

Journal • P2 data • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease • Ulcerative Colitis

Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment (clinicaltrials.gov) - P2 | N=150 | Not yet recruiting | Sponsor: Jina Pharmaceuticals Inc.

New P2 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis